U.S. Capital Markets Stock News

FAA certifies the Boeing 737 MAX 7 for commercial service after a multi year approval process. Certification clears the way for first MAX 7 deliveries to Southwest Airlines. Approval represents the first new Boeing aircraft to receive FAA clearance since the MAX crisis began. Regulatory sign off follows years of heightened oversight of Boeing's safety and compliance processes. Boeing, ticker NYSE:BA, now has FAA certification for the 737 MAX 7, which allows the aircraft to enter commercial...

Verisk Analytics (NasdaqGS:VRSK) has announced that long-serving EVP and CIO Nick Daffan is stepping down after more than two decades with the company. The company’s CTO will assume interim CIO responsibilities as Verisk continues to focus on advanced analytics, cloud infrastructure and AI-related initiatives. Verisk Analytics operates as a data and analytics provider with a strong focus on insurance and risk-related solutions. The company has invested heavily in cloud migration and digital...

Markets are trying to make sense of Fed Chair Kevin Warsh’s new hands off stance on inflation, with long term yields at 19 year highs and volatility back in focus. When policy guidance feels uncertain, large banking and financial services stocks can either absorb the shock or feel it more sharply, depending on how their funding, lending and trading books respond to higher yields and shifting risk appetite. This article looks at three financially solid stocks from our screener that appear...

Roku (ROKU) is drawing fresh attention as Wall Street analysts look ahead to its upcoming quarterly report, with expectations focused on stronger earnings, higher revenue, and mixed trends across its platform and device businesses. See our latest analysis for Roku. Roku's share price has climbed over the past year, with a 90 day share price return of 13.96% and year to date share price return of 34.14%. At the same time, the 1 year total shareholder return of 74.37% contrasts with a 5 year...

Graphic Packaging Holding Company has released its second-quarter 2026 results, with sales of US$2,188 million holding roughly steady year on year while net income dropped to US$24 million and earnings per share from continuing operations declined to US$0.08. Despite this sharp profitability squeeze and a net loss over the first half of 2026, the company’s Board still affirmed a quarterly dividend of US$0.11 per share, underscoring an ongoing commitment to returning cash to...

Anterix (ATEX) has drawn fresh attention after recent trading left the stock around $95.65, with short term moves contrasting with a stronger performance over the past 3 months and year to date. See our latest analysis for Anterix. Recent price action in Anterix points to strong momentum, with a 1 day share price return of 2.83% and a 7 day gain of 4.68%, set against a softer 30 day share price return showing a 9.03% decline. Even so, the 90 day share price return of 84.23%, year to date gain...

Recent commentary on Appian highlights growing investor attention to its valuation and role in enterprise automation software, particularly as AI adoption accelerates across regulated industries. Analysts and valuation models now paint a mixed picture, with some seeing the shares as undervalued on cash flow and multiple checks while others view them as slightly overvalued relative to fair value estimates. With Appian’s positioning in AI-driven enterprise automation under the spotlight, we’ll...

Liquidia (LQDA) has drawn attention after a very large 52 week gain of more than 360%, along with a 100% technical "Buy" opinion and supportive analyst sentiment regarding future revenue and earnings projections. See our latest analysis for Liquidia. At a latest share price of US$83.85, Liquidia’s recent pullback over the past week sits against a strong 30 day share price return of 6.23% and a very large 1 year total shareholder return of 317.79%. This points to momentum that has been...

Tower Semiconductor Ltd. has reported past second-quarter 2026 results showing sales of US$460.08 million and net income of US$90.77 million, with both basic and diluted earnings per share from continuing operations rising compared with the same period a year earlier. Across the first half of 2026, the company’s higher revenue and earnings per share suggest improved operating efficiency and profitability against its prior-year performance baseline. We’ll now examine how this stronger...

QCR Holdings (QCRH) has drawn fresh attention after reporting second quarter 2026 results that showed higher net interest income and net income year over year, along with declining net charge offs as the m2 portfolio winds down. See our latest analysis for QCR Holdings. At a share price of $104.40, QCR Holdings has seen momentum build, with a 30 day share price return of 8.02% and a year to date share price return of 27.10%, while the 1 year total shareholder return of 47.47% sits within a...

Enova International stock has delivered a very large 5 year return, yet its current valuation checks lean on the expensive side rather than pointing to a clear bargain. Over 5 years, Enova International has returned close to 7x an initial investment, which puts extra focus on whether the recent share price reflects fundamentals. Recent earnings strength can support expectations for continued profit generation. However, any slowdown in growth or pressure on credit quality may weigh on what...

The U.S. Department of Energy has granted Oklo (OKLO) startup authorization for its Groves Isotope Test Reactor, a key regulatory step that now allows fuel loading, startup testing and initial reactor operations to begin. See our latest analysis for Oklo. The startup authorization lands after a tough stretch for the Oklo share price, which is down 47% year to date and has fallen 48% over the past 90 days, even though the 3 year total shareholder return is very large. The recent 1 day share...

AbbVie (ABBV) lifted its full year 2026 revenue guidance to about US$67.6b, adding US$300m to its outlook, while also issuing third quarter revenue guidance and reporting detailed second quarter results. See our latest analysis for AbbVie. Despite AbbVie lifting its 2026 revenue outlook and reporting higher second quarter sales and net income, the stock has recently cooled, with the 7 day share price return down 6.88% and the 30 day share price return down 6.12%. That comes after a stronger...

A calmer backdrop after the called off U.S. strikes on Iran, softer oil prices, and renewed confidence in megacap technology have helped improve sentiment around US blue chip dividend stocks. For income focused investors, that mix can make dependable payers with strong balance sheets look more interesting, especially as the S&P 500 recently recovered from a technology led selloff. This article looks at how those catalysts relate to three individual dividend stocks in the screener and why...

In the past quarter, Certara, Inc. reported second-quarter 2026 sales of US$93.27 million versus US$92.36 million a year earlier, but its net loss widened sharply to US$55.27 million from US$1.97 million, driving basic loss per share from continuing operations to US$0.04. Across the first half of 2026, sales inched up to US$187.36 million from US$184.46 million, yet the company swung from a US$2.78 million profit to a US$64.03 million loss, suggesting that higher costs or investments...

La-Z-Boy Incorporated recently launched The Jer-Z-Boy, a custom recliner collaboration with fashion and sports culture figure Kristin Juszczyk, featuring three one-of-a-kind, team-inspired chairs, a fan sweepstakes, and a Labor Day promotion with free in-home design services. This partnership brings Juszczyk’s fashion-forward sports aesthetic into furniture for the first time, potentially deepening La-Z-Boy’s connection with younger, sports-focused consumers and reinforcing its brand as...

Zeta Global announced that Trey Campbell became Senior Vice President of Investor Relations on July 27, 2026, succeeding Matt Pfau as he moved into the Senior Vice President, Financial Planning & Analysis role. Campbell’s long tenure in technology finance and investor relations at Synopsys, Luminar Technologies, and Intel brings deep capital-markets experience to how Zeta communicates its performance and long-term ambitions. Next, we’ll consider how bringing in a veteran investor relations...

Pacira BioSciences (PCRX) has advanced PCRX-201, its osteoarthritis gene therapy candidate, to a scalable U.S. commercial manufacturing process and has begun enrolling patients in Part B of the Phase 2 ASCEND study. See our latest analysis for Pacira BioSciences. The latest PCRX-201 update comes as Pacira BioSciences trades at US$26.92, with a 30 day share price return of 6.03% and a 90 day share price return of 13.63%. Over five years, the total shareholder return has declined 52.07%,...

Essex Property Trust (ESS) is back in focus after releasing second quarter 2026 results that paired higher revenue with a sharply lower net income figure and a trimmed full year earnings outlook. See our latest analysis for Essex Property Trust. Despite the softer second quarter and lowered 2026 earnings guidance, Essex Property Trust’s share price has a year to date share price return of 11.29% and a 1 year total shareholder return of 15.51%. This signals momentum that has cooled in recent...

Tariffs are back in the headlines, with 25 states challenging the Trump administration’s latest round that touches nearly all U.S. imports from 59 countries and the EU. For U.S. Domestic Manufacturing Stocks, this legal and trade backdrop can change the balance between import heavy companies and those with a stronger local production base. Higher costs and supply chain friction may hurt some businesses and create openings for others. This article breaks down how that trade shock could matter...

Entravision Communications (EVC) has drawn investor attention after recent trading, with the stock down about 15% over the past month yet up roughly 44% in the past 3 months. See our latest analysis for Entravision Communications. Zooming out, Entravision Communications has seen short term momentum cool, with a 1 month share price return of about a 15% decline, while a very strong 1 year total shareholder return of around 413% points to powerful longer term gains. If you are looking for other...

Alexandria Real Estate Equities, Inc. reported second-quarter 2026 revenue of US$662.78 million with a US$72.78 million net loss, while its six-month results showed revenue of US$1,333.81 million and net income of US$288.87 million, alongside progress on the MAP-D depression research initiative with the Foundation for the National Institutes of Health. The MAP-D collaboration, now through its critical design phase and moving toward a research effort expected to exceed US$70 million,...

Eli Lilly (NYSE:LLY) received U.S. FDA Breakthrough Therapy designation for olomorasib. The designation covers olomorasib as a monotherapy in previously treated, KRAS G12C-mutant advanced pancreatic cancer. This mutation currently has no approved targeted therapies in pancreatic cancer. The decision marks a significant regulatory milestone in Lilly’s oncology pipeline. Eli Lilly has built strong investor attention around its diabetes and obesity treatments, and this new FDA designation...

BioNTech SE has reported past second-quarter 2026 results showing sales of €105.6 million versus €260.8 million a year earlier, with net loss widening to €820.8 million and basic loss per share from continuing operations increasing to €3.24 from €1.60. At the same time, the Supervisory Board has moved to refresh leadership by appointing experienced biopharma executive Guido Oelkers as future CEO, a shift that could influence how BioNTech balances heavy R&D spending with efforts to broaden...